leisure time -WSS

leisure time

author：explore 2025-09-03 03:27:24 - browse：6

Adam's take main illustration — Molly Ferguson/STAT

CHICAGO — Something is off about the way Novartis is talking about pelabresib, its newly acquired and costly treatment for myelofibrosis. I suspect the Swiss pharma giant’s previously stated plan to submit a marketing application to the Food and Drug Administration this year has been blocked.

I’m not just speculating wildly. It’s looking increasingly likely that the $3 billion purchase of MorphoSys to acquire pelabresib — a deal pushed hard by top Novartis executive strategist Ronny Gal over some internal dissent — has run into serious trouble just days after the closing.

On Sunday evening, Novartis Chief Medical Officer Shreeram Aradhye, speaking at the company’s ASCO investor event here in Chicago, offered this response to an analyst who asked about pelabresib.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： A Q&A with the global head of Boehringer Ingelheim's innovation unit

hotspot

WSS

3 questions for the future of Biden's cancer moonshot

Stroke deaths set to near 10 million globally by 2050

VC firm RA Capital starts a new synthetic biology incubator

Timeline: Special counsel's probe into Trump's handling of classified documents

Why age limits for politicians are a terrible idea

'The boss' wants server deleted: New allegations emerge in Trump indictment

entertainment

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

New air purifier tech could be key to improving indoor air quality

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

Alkermes shareholders re

Why age limits for politicians are a terrible idea

Medicare proposal to cover medical devices draws a mixed reaction

Physician executives need more than on

Medicare details structure of new drug price negotiation program

Physician executives need more than on

Wildfire smoke exposes gaps in outdoor worker protections

Alexander Hamilton and the argument for universal insurance

hotspot

Will biotech layoffs continue through 2023?

As the dark side of IVF slowly comes into focus, even more transparency is needed

Histogen: Failed biotech offers rare public look inside

The mammogram wars are not over

As the dark side of IVF slowly comes into focus, even more transparency is needed

3 questions for the future of Biden's cancer moonshot

Wikipedia

hotspot

hotspot

hotspot